Currently out of the existing stock ratings of Conor Mcnamara, 160 are a BUY (83.77%), 31 are a HOLD (16.23%).

Conor Mcnamara

Work Performance Price Targets & Ratings Chart

Analyst Conor Mcnamara, carries an average stock price target met ratio of 42.18% that have a potential upside of 34.44% achieved within 204 days. Previously, Conor Mcnamara worked at RBC.

Conor Mcnamara’s has documented 379 price targets and ratings displayed on 14 stocks. The coverage was on Basic Materials, Healthcare sectors.

Most recent stock forecast was given on NTRA, Natera at 12-Jun-2026.

Wall Street Analyst Conor Mcnamara

Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for NTRA (NATERA) at 6/12/2026. The price target of $275 was fulfilled within 19 days with a profit of $62.93 (29.67%) receiving and performance score of 15.62.

Average potential price target upside

AVTR Avantor BIO Bio-Rad Laboratories DHR Danaher EXAS EXACT Sciences HOLX Hologic ILMN Illumina MRVI Maravai Lifesciences Holdings  NTRA Natera OABI OmniAb QDEL Quidel RGEN Repligen SOPH Sophia Genetics SA TECH Bio-Techne Corp TMO Thermo Fisher Scientific

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Sep-2026

$16

$1.12 (7.53%)

$29

Hold Since 04-Aug-2025

$14

$-0.88 (-5.91%)

$12

1 months 12 days ago
(30-Jul-2026)

11/20 (55%)

$0.14 (1.01%)

99

Hold Since 04-Aug-2025

$15

$0.12 (0.81%)

$12

1 months 12 days ago
(30-Jul-2026)

9/13 (69.23%)

$1.14 (8.23%)

53

Hold Since 06-Apr-2026

$14

$-0.88 (-5.91%)

$10.5

1 months 12 days ago
(30-Jul-2026)

11/15 (73.33%)

$0.14 (1.01%)

39

Buy Since 11-Jun-2019

$16

$1.12 (7.53%)

$14

1 months 12 days ago
(30-Jul-2026)

4/7 (57.14%)

$2.14 (15.44%)

206

Show more analysts

Please expand the browser size to see the chart

Which stock is Conor Mcnamara most bullish on?

Potential upside of $-5.05 has been obtained for RGEN (REPLIGEN)

Which stock is Conor Mcnamara most reserved on?

Potential downside of -$115.69 has been obtained for TMO (THERMO FISHER SCIENTIFIC)

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?